Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04798586
What this trial is testing

MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Pfizer 4
Early research (Phase 1)Ended earlyNCT03936959
What this trial is testing

LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 10
Not applicableUnknownNCT03318770
What this trial is testing

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Early research (Phase 1)Looking for participantsNCT05999396
What this trial is testing

FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerBreast CarcinomaSarcoma+1 more
German Cancer Research Center 89
Early research (Phase 1)Looking for participantsNCT07813637
What this trial is testing

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more
Janux Therapeutics 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524634
What this trial is testing

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Case Comprehensive Cancer Center 64
Early research (Phase 1)Study completedNCT03751709
What this trial is testing

Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL

Who this might be right for
B-Cell Acute Lymphoblastic LeukaemiaALL, AdultB-ALL
Cedars-Sinai Medical Center 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140500
What this trial is testing

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid TumorsMetastatic MelanomaNon-small Cell Lung Cancer+1 more
Hoffmann-La Roche 170
Testing effectiveness (Phase 2)Looking for participantsNCT06806033
What this trial is testing

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Who this might be right for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07757412
What this trial is testing

Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma Progression
Odense University Hospital 50
Early research (Phase 1)Looking for participantsNCT05607498
What this trial is testing

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

Who this might be right for
Advanced/Metastatic Solid TumorsRelapse/Refractory Lymphoma
EpimAb Biotherapeutics (Suzhou)Co., Ltd. 150
Not applicableLooking for participantsNCT05106387
What this trial is testing

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 20
Early research (Phase 1)Study completedNCT02324257
What this trial is testing

RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 149
Early research (Phase 1)Looking for participantsNCT06663839
What this trial is testing

NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Light Chain Bioscience - Novimmune SA 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03272334
What this trial is testing

Her2-BATS and Pembrolizumab in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Virginia 22
Early research (Phase 1)Ended earlyNCT04009460
What this trial is testing

ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsNeoplasmsMalignant Tumor
Elpiscience Biopharma, Ltd. 22
Large-scale testing (Phase 3)Looking for participantsNCT06152575
What this trial is testing

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Who this might be right for
Multiple Myeloma
Pfizer 492
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06196775
What this trial is testing

Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Harbin Medical University 36
Early research (Phase 1)Study completedNCT01284231
What this trial is testing

Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Who this might be right for
Gastrointestinal Adenocarcinomas
MedImmune LLC 78
Early research (Phase 1)Study completedNCT05559554
What this trial is testing

Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

Who this might be right for
Healthy Male Subjects
Akeso 100
Next Page